跳至主要内容
临床试验/NL-OMON53040
NL-OMON53040招募中不适用

Complex fractionated atrial electrocardiograms (CFAEs) guided ablation versus pulmonary vein isolation guided ablation in persistent atrial fibrillation, a multicenter randomized trial - CIPA

Isala Klinieken0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with persistent atrial fibrillation, defined as atrial fibrillation
  • a. Sustained beyond 7 days but no more than one year
  • b. Or lasting less than 7 days, but longer than 48 hours and necessitating
  • pharmacologic or electrical cardioversion
  • 2. Documentation of atrial fibrillation on either a 12-lead ECG or
  • transtelephonic monitoring (TTM), or ambulatory holter monitoring or telemetry
  • strip and a physician*s note showing continuous AF.
  • 3. Failure of at least one antiarrhythmic drug (AAD) (Class I or III) as
  • evidenced by recurrent symptomatic AF or intolerable side effects of the AAD.

排除标准

  • 1. Continuous AF > 12 months (1-Year) (Longstanding Persistent AF)
  • 1. Previous surgical or catheter ablation for atrial fibrillation
  • 2. Any cardiac surgery within the past 2 months (60 days) (includes PCI)
  • 3. CABG surgery within the past 6 months (180 days)
  • 4. Subjects that have ever undergone valvular cardiac surgical procedure
  • 5. Cardioversion refractory (the inability to restore sinus rhythm for 30 secs
  • or longer following electrical cardioversion).
  • 6. Documented LA thrombus on imaging
  • 7. LA size >50 mm
  • 8. LVEF < 30%

研究者

发起方
Isala Klinieken

相似试验